These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8879993)

  • 21. [From gene to disease; achondroplasia and other skeletal dysplasias due to an activating mutation in the fibroblast growth factor].
    van Ravenswaaij-Arts CM; Losekoot M
    Ned Tijdschr Geneeskd; 2001 Jun; 145(22):1056-9. PubMed ID: 11414167
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Osteogenesis imperfecta and other inherited disorders of the structure and synthesis of type I collagen: models for the analysis of mutations that result in inherited chondrodysplasias.
    Cohn DH; Byers PH
    Pathol Immunopathol Res; 1988; 7(1-2):132-8. PubMed ID: 3065765
    [No Abstract]   [Full Text] [Related]  

  • 23. Cardiac malformation in two infants with hypochondrogenesis.
    Potocki L; Abuelo DN; Oyer CE
    Am J Med Genet; 1995 Nov; 59(3):295-9. PubMed ID: 8599352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Osteochondrodysplasia determined genetically by a collagen type II gene mutation].
    Czarny-Ratajczak M; Rogala P; Wolnik-Brzozowska D; Latos-Bieleńska A
    Chir Narzadow Ruchu Ortop Pol; 2001; 66(1):79-86. PubMed ID: 11481990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cytokines in bone diseases. FGF receptor signaling and achondroplasia/hypochondroplasia].
    Tanaka H
    Clin Calcium; 2010 Oct; 20(10):1490-6. PubMed ID: 20890030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Parathyroid hormone receptor type 1/Indian hedgehog expression is preserved in the growth plate of human fetuses affected with fibroblast growth factor receptor type 3 activating mutations.
    Cormier S; Delezoide AL; Benoist-Lasselin C; Legeai-Mallet L; Bonaventure J; Silve C
    Am J Pathol; 2002 Oct; 161(4):1325-35. PubMed ID: 12368206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Parathyroid hormone (PTH)/PTHrP receptor mutations in human chondrodysplasia.
    Nissenson RA
    Endocrinology; 1998 Dec; 139(12):4753-5. PubMed ID: 9832410
    [No Abstract]   [Full Text] [Related]  

  • 28. Pseudoachondroplasia and multiple epiphyseal dysplasia due to mutations in the cartilage oligomeric matrix protein gene.
    Briggs MD; Hoffman SM; King LM; Olsen AS; Mohrenweiser H; Leroy JG; Mortier GR; Rimoin DL; Lachman RS; Gaines ES
    Nat Genet; 1995 Jul; 10(3):330-6. PubMed ID: 7670472
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The type II collagenopathies: a spectrum of chondrodysplasias.
    Spranger J; Winterpacht A; Zabel B
    Eur J Pediatr; 1994 Feb; 153(2):56-65. PubMed ID: 8157027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FGFR3 gene mutations in transmembrane domain in Chinese achondroplasia and hypochondroplasia patients.
    Yan-Ling G; Ji-Hong N; Guo-Qiang L; Wei W; De-Fen W
    Horm Res; 1998; 49 Suppl 1():57. PubMed ID: 9554479
    [No Abstract]   [Full Text] [Related]  

  • 31. [Molecular basis of achondroplasia, hypochondroplasia, and thanatophoric dysplasia].
    Moskalewski S; Hyc A; Osiecka-Iwan A; Strzelczyk P
    Chir Narzadow Ruchu Ortop Pol; 2000; 65(3):327-33. PubMed ID: 11057021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Occurrence of thanatophoric dysplasia type I (R248C) and hypochondroplasia (N540K) mutations in two patients with achondroplasia phenotype.
    Camera G; Baldi M; Strisciuglio G; Concolino D; Mastroiacovo P; Baffico M
    Am J Med Genet; 2001 Dec; 104(4):277-81. PubMed ID: 11754059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hereditary skeletal dysplasias and FGFR3 and PTHR1 signaling pathways].
    Bonaventure J; Silve C
    Med Sci (Paris); 2005 Nov; 21(11):954-61. PubMed ID: 16274647
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathogenic mechanisms in osteochondrodysplasias.
    Stanescu V; Stanescu R; Maroteaux P
    J Bone Joint Surg Am; 1984 Jul; 66(6):817-36. PubMed ID: 6376516
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suppressing UPR-dependent overactivation of FGFR3 signaling ameliorates SLC26A2-deficient chondrodysplasias.
    Zheng C; Lin X; Xu X; Wang C; Zhou J; Gao B; Fan J; Lu W; Hu Y; Jie Q; Luo Z; Yang L
    EBioMedicine; 2019 Feb; 40():695-709. PubMed ID: 30685387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pseudoachondroplasia and multiple epiphyseal dysplasia: mutation review, molecular interactions, and genotype to phenotype correlations.
    Briggs MD; Chapman KL
    Hum Mutat; 2002 May; 19(5):465-78. PubMed ID: 11968079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone dysplasias in man: molecular insights.
    Francomano CA; McIntosh I; Wilkin DJ
    Curr Opin Genet Dev; 1996 Jun; 6(3):301-8. PubMed ID: 8791509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heritable diseases of the skeleton. Part II: Molecular insights into skeletal development-matrix components and their homeostasis.
    Mundlos S; Olsen BR
    FASEB J; 1997 Mar; 11(4):227-33. PubMed ID: 9068611
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A homozygous inactivating mutation in the parathyroid hormone/parathyroid hormone-related peptide receptor causing Blomstrand chondrodysplasia.
    Zhang P; Jobert AS; Couvineau A; Silve C
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3365-8. PubMed ID: 9745456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia.
    Naski MC; Wang Q; Xu J; Ornitz DM
    Nat Genet; 1996 Jun; 13(2):233-7. PubMed ID: 8640234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.